Blockade of protein kinase A (PKA) localization augments the trafficking and anti-tumor efficacy of adoptively transferred chimeric antigen receptor-expressing T cells

被引：0
|
作者：
Newick, Kheng
O'Brien, Shaun
Sun, Jing
Kapoor, Veena
Maceyko, Steve
Lo, Albert
Pure, Ellen
Moon, Ed K.
Albelda, Steven M.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.TME16-B27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B27
引用
收藏
页数：3
相关论文
共 50 条
  • [21] CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro
    Khadijeh Alishah
    Matthias Birtel
    Elham Masoumi
    Leila Jafarzadeh
    Hamid Reza Mirzaee
    Jamshid Hadjati
    Ralf-Holger Voss
    Mustafa Diken
    Sedighe Asad
    Journal of Translational Medicine, 19
  • [22] CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
    Rupp, Levi J.
    Schumann, Kathrin
    Roybal, Kole T.
    Gate, Rachel E.
    Ye, Chun J.
    Lim, Wendell A.
    Marson, Alexander
    SCIENTIFIC REPORTS, 2017, 7
  • [23] PRDM1 knockout chimeric antigen receptor-natural killer cells exhibit durable anti-tumor efficacy
    Nakashima, Takahiro
    Yoshikawa, Toshiaki
    Matsukawa, Tetsuya
    Ito, Yusuke
    Inoue, Satoshi
    Iida, Shinsuke
    Kagoya, Yuki
    CANCER SCIENCE, 2025, 116 : 98 - 98
  • [24] Total body irradiation enhances the anti-tumor efficacy of adoptively transferred CD8+T cells stimulated ex vivo with IL-12
    Johnson, C. Bryce
    Cloud, Colleen
    Rubinstein, Mark
    Cole, David
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [25] Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
    Guo, Xingliang
    Jiang, Hua
    Shi, Bizhi
    Zhou, Min
    Zhang, Honghong
    Shi, Zhimin
    Du, Guoxiu
    Luo, Hong
    Wu, Xiuqi
    Wang, Yi
    Sun, Ruixin
    Li, Zonghai
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [26] A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers
    Wei, Jing
    Sun, Huiyan
    Zhang, Aimei
    Wu, Xuejie
    Li, Yuxiang
    Liu, Jiawei
    Duan, Yanting
    Xiao, Fengjun
    Wang, Hua
    Lv, Ming
    Wang, Lisheng
    Wu, Chutse
    CELLULAR IMMUNOLOGY, 2018, 331 : 49 - 58
  • [27] CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells
    Kowolik, Claudia M.
    Topp, Max S.
    Gonzalez, Sergio
    Pfeiffer, Timothy
    Olivares, Simon
    Gonzalez, Nancy
    Smith, David D.
    Forman, Stephen J.
    Jensen, Michael C.
    Cooper, Laurence J. N.
    CANCER RESEARCH, 2006, 66 (22) : 10995 - 11004
  • [28] PD-1 RNA Interference Contained in a Mesothelin Chimeric Antigen Receptor T Cells Display Enhanced Anti-Tumor Activities
    Kang, Xi
    MOLECULAR THERAPY, 2019, 27 (04) : 273 - 274
  • [29] PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity
    Wei, Jianshu
    Luo, Can
    Wang, Yao
    Guo, Yelei
    Dai, Hanren
    Tong, Chuan
    Ti, Dongdong
    Wu, Zhiqiang
    Han, Weidong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [30] Disruption of tumor-promoting desmoplasia by adoptive transfer of fibroblast activation protein targeted chimeric antigen receptor (CAR) T cells enhances anti-tumor immunity and immunotherapy.
    Xiao, Zebin
    Hopper, Leslie A.
    Kopp, Meghan C.
    McMillan, Emily
    Li, Yue
    Barrett, Richard L.
    Pure, Ellen
    CANCER RESEARCH, 2022, 82 (22) : 117 - 117
12345